SeqOnce Biosciences Revenue

Biotechnology Research • 1926 Kellogg Ave, Carlsbad, United States • 1-10 Employees

SeqOnce Biosciences revenue & valuation

Annual revenue	$684,440
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,200,000
Total funding	No funding

Key Contacts at SeqOnce Biosciences

Chris Angermayer

President & Ceo | Co-Founder

Joseph P. Dunham

Co-Founder | Chief Science Officer

Lyle Rawlings

Director Of Assay Development

Company overview

Headquarters	1926 Kellogg Ave, Carlsbad, California 92008, US
Phone number	+110076042
Website	seqonce.com
NAICS	541714
SIC	873
Keywords	Diagnostics, PCR, Next Generation Sequencing, Genomics
Founded	2014
Employees	1-10
Socials

SeqOnce Biosciences Email Formats

SeqOnce Biosciences uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@seqonce.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@seqonce.com	100%

About SeqOnce Biosciences

SeqOnce Biosciences is a privately held company located in Carlsbad, California. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development. SeqOnce Biosciences was formed in 2014 by Joseph Dunham, Ph.D, a researcher at the University of Southern California and Chris Angermayer, a former portfolio manager and investment analyst. The founders are dedicated to building a team of individuals who are leaders in the industry, thereby enabling SeqOnce to become a preeminent player in the NGS sample preparation market.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Director

Employees by Department

SeqOnce Biosciences has 4 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore SeqOnce Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-11-26	3	N/A

Funding Insights

Number of funding rounds

SeqOnce Biosciences Tech Stack

Discover the technologies and tools that power SeqOnce Biosciences's digital infrastructure, from frameworks to analytics platforms.

Gravity Forms

Form builders

DataTables

JavaScript libraries

jQuery UI

JavaScript libraries

Hello Elementor

WordPress themes

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Redis

Databases

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

Frequently asked questions

SeqOnce Biosciences is located in 1926 Kellogg Ave, Carlsbad, US.

You can reach SeqOnce Biosciences at +110076042.

SeqOnce Biosciences generates an estimated annual revenue of $684,440. This revenue figure reflects the company's market position and business performance in its industry.

SeqOnce Biosciences has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SeqOnce Biosciences was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

SeqOnce Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at SeqOnce Biosciences

Chris Angermayer

President & Ceo | Co-Founder

Joseph P. Dunham

Co-Founder | Chief Science Officer

Lyle Rawlings

Director Of Assay Development

4.8

40,000 users